| Literature DB >> 33840162 |
Michael Y Shino1, Ning Li1, Jamie L Todd2, Megan L Neely3, Jerry Kirchner4, Heather Kopetskie5, Michelle L Sever5, Courtney W Frankel2, Laurie D Snyder2, Elizabeth N Pavlisko6, Tereza Martinu7, Lianne G Singer7, Wayne Tsuang8, Marie Budev8, Pali D Shah9, John M Reynolds2, Nikki Williams10, Mark A Robien10, Scott M Palmer2, Stephen Sam Weigt1, John A Belperio1.
Abstract
The histopathologic diagnosis of acute allograft injury is prognostically important in lung transplantation with evidence demonstrating a strong and consistent association between acute rejection (AR), acute lung injury (ALI), and the subsequent development of chronic lung allograft dysfunction (CLAD). The pathogenesis of these allograft injuries, however, remains poorly understood. CXCL9 and CXCL10 are CXC chemokines induced by interferon-γ and act as potent chemoattractants of mononuclear cells. We hypothesized that these chemokines are involved in the mononuclear cell recruitment associated with AR and ALI. We further hypothesized that the increased activity of these chemokines could be quantified as increased levels in the bronchoalveolar lavage fluid. In this prospective multicenter study, we evaluate the incidence of histopathologic allograft injury development during the first-year post-transplant and measure bronchoalveolar CXCL9 and CXCL10 levels at the time of the biopsy. In multivariable models, CXCL9 levels were 1.7-fold and 2.1-fold higher during AR and ALI compared with "normal" biopsies without histopathology. Similarly, CXCL10 levels were 1.6-fold and 2.2-fold higher during these histopathologies, respectively. These findings support the association of CXCL9 and CXCL10 with episodes of AR and ALI and provide potential insight into the pathogenesis of these deleterious events.Entities:
Keywords: cytokines/cytokine receptors; immunobiology; lung disease: immune/inflammatory; lung failure/injury; lung transplantation/pulmonology; rejection: acute; translational research/science
Mesh:
Substances:
Year: 2021 PMID: 33840162 PMCID: PMC8502500 DOI: 10.1111/ajt.16601
Source DB: PubMed Journal: Am J Transplant ISSN: 1600-6135 Impact factor: 9.369